| Term 
 
        | HIV Attachment/Fusion inhibitors examples |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | maraviroc category, mode of action, screening, indication? |  | Definition 
 
        | anti HIV attachment/fusion inhibitor; CCR5 receptor antagonist, blocks attachment of HIV pg120 to T-cell; must do CCR5 tropism test as some HIV use CCR5 while others use CXCR4 co-receptor on T-cell; use only in combination therapy if other drugs fail. |  | 
        |  | 
        
        | Term 
 
        | enfuvirtide category, mode of action |  | Definition 
 
        | anti HIV attachment/fusion inhibitor; binds to HIV's intracellular gp41 and prevents fusion of HIV capsid and T-cell cell membrane AFTER HIV has attached to T-cell via gp120 and T-cell CD4 receptor |  | 
        |  | 
        
        | Term 
 
        | HIV reverse transcriptase inhibitors: 2 categories, examples from each |  | Definition 
 
        | nucleoside (zidovudine, didanosine, stavudine, abacavir, zalcitabine, emtricitabine, tenofovir) "TAZES DogZ"; non-nucleoside (nevirapine, delavirdine, efavirene) "DEN" |  | 
        |  | 
        
        | Term 
 
        | nucleoside reverse transcriptase inhibitors mode of action, indication, SE (why)? |  | Definition 
 
        | competes with native nucleotides, resulting in termination of DNA synthesis; for HIV 1 or 2 (West African); SE: b/c human gamma DNA polymerase in mitochondia has some affinity for these drugs...1)severe peripheral neuropathy 2) pancreatitis 3) hematoxicity "HIV HaPpeNs" |  | 
        |  | 
        
        | Term 
 
        | Zidovudine mode of action, tx, SE? |  | Definition 
 
        | Nucleoside reverse transcriptase inhibitor; HIV combination therapy (use two different ones); SE: severe peripheral neuropathy |  | 
        |  | 
        
        | Term 
 
        | Didanosine mode of action, tx, SE? |  | Definition 
 
        | Nucleoside reverse transcriptase inhibitor; HIV combination therapy (use two different ones); SE: severe peripheral neuropathy, pancreatitis |  | 
        |  | 
        
        | Term 
 
        | Stavudine mode of action, tx, SE? |  | Definition 
 
        | Nucleoside reverse transcriptase inhibitor; HIV combination therapy (use two different ones); SE: severe peripheral neuropathy (71%) and lipo-atropy |  | 
        |  | 
        
        | Term 
 
        | abacavir mode of action, tx, SE? |  | Definition 
 
        | Nucleoside reverse transcriptase inhibitor; HIV combination therapy (use two different ones); SE: If HLA-B*5701 gene-> multisystem hypersensitivity -> becomes life threatening (screen, 5-8%) |  | 
        |  | 
        
        | Term 
 
        | non-nucleoside reverse transcriptase inhibitors root, mode of action, advantage, indication, metabolism, SEs (3)? |  | Definition 
 
        | -vir-; non competitive inhibitors of HIV reverse transcriptase; don't have to be phosphorylated, highly selective; only for HIV 1; CYP450 3A4 (inhibit: azole antifungal, cimetidine, erythromycin, grapefruit juice; induce: rifampin, carbamazepine, phenytoin, St. John's wort); SE: 1)temporary rash 2) hepatitis 3) CNS (temporary insomnia, vivid dreams)...RHC Really Hard Core HIV |  | 
        |  | 
        
        | Term 
 
        | Nevirapine mode of action, tx, SE? |  | Definition 
 
        | Non-nucleoside reverse transcriptase inhibitor; HIV combination therapy (use one with two different NRTI); SE: rash, hepatitis |  | 
        |  | 
        
        | Term 
 
        | Delavirdine mode of action, tx, SE? |  | Definition 
 
        | Non-nucleoside reverse transcriptase inhibitor; HIV combination therapy (use one with two different NRTI); SE: rash |  | 
        |  | 
        
        | Term 
 
        | Efavirene mode of action, tx, SE? |  | Definition 
 
        | Non-nucleoside reverse transcriptase inhibitor; HIV combination therapy (use one with two different NRTI); SE: rash, CNS: insomnia, vivid dreams (53%) |  | 
        |  | 
        
        | Term 
 
        | HIV integrase inhibitors mode of action, indication, example |  | Definition 
 
        | blocks activity of HIV integrase; used in combination therapy; raltegravir |  | 
        |  | 
        
        | Term 
 
        | HIV protease inhibitors ending, mode of action, indication, metabolism, SEs (4)? |  | Definition 
 
        | -navir; aspartyl proteases that cleave nacent HIV proteins into active proteins are inhibited, rendering virus non-infectious; combination therapy (one PI with two different NRTIs); CYP450 3A4 (also inhibits: saquinavir least, ritonavir most inhibiting...ritonavir boost increases action of other PIs); SE: 1) Lipodystrophy (buffalo hump: gain, facial wasting: loss, crix belly/protease paunch from Crixivan aka indinavir. 2) metabolic syndrome (X): central obesity, increased bp, increased TG, decreased HDL, insulin resistance (inhibits carb metabolism) -> increased risk of cardiovascular disease 3) diarrhea 4) night sweats ... LMDN Let Me Die Now from HIV |  | 
        |  | 
        
        | Term 
 
        | ritonavir mode of action, metabolism effect; use |  | Definition 
 
        | HIV protease inhibitor; most inhibiting of CYP450 3A4 (which metabolizes protease inhibitors); can be used as a ritonavir boost to increase activity of other HIV protease inhibitors |  | 
        |  | 
        
        | Term 
 
        | HAART? recommendation? signs of success? combinations to avoid? |  | Definition 
 
        | Highly active antiretroviral therapy; 2 NRTI + 1 NNRTI (or 1 PI); decreased viral load, resistance, opportunistic infections, increased CD4 count (T-cells); NO: stavudine + didanosine (same side effects: dose limited peripheral neuropathy) AND NO: stavudine + zidovudine (thymidine analogs that compete for HIV reverse transcriptase binding) |  | 
        |  |